Evidence map›Paper›PMID 28303492›Full record

ReviewCurrent oncology reports2017

Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies.

Masayuki Futagami, Yoshihito Yokoyama, Muneaki Shimada, Shinya Sato, Etsuko Miyagi, Akiko Tozawa-Ono, Nao Suzuki, Masaki Fujimura, Yoichi Aoki, Satoru Sagae and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current oncology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Masayuki FutagamiDepartment of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan. futagami@hirosaki-u.ac.jp.
Yoshihito YokoyamaDepartment of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Muneaki ShimadaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University, Sendai, 980-8574, Japan.
Shinya SatoDepartment of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, Yonago, 683-8504, Japan.
Etsuko MiyagiDepartment of Obstetrics and Gynecology, Yokohama City University Hospital, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Akiko Tozawa-OnoDepartment of Obstetrics and Gynecology, St. Marianna University School of Medicine, 2-16-1 Sugo, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Nao SuzukiDepartment of Obstetrics and Gynecology, St. Marianna University School of Medicine, 2-16-1 Sugo, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Masaki FujimuraDepartment of Obstetrics and Gynecology, Tokyo Medical University Ibaraki Medical Center, 3-20-1 Chuo, Ami-cho, Inashiki-gun, Ibaraki, 300-0395, Japan.
Yoichi AokiDepartment of Obstetrics and Gynecology, Graduate School of Medical Science, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan.
Satoru SagaeGynecologic Oncology, Sapporo West Kojinkai Clinic, 1-1-1-30 Miyanosawa, Nishi-ku, Sapporo, 063-0051, Japan.
Toru SugiyamaDepartment of Obstetrics and Gynecology, Iwate Medical University, 19-1, Uchimaru, Morioka, Iwate, 020-8505, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Japanese Gynecologic Oncology Group (JGOG) is leading Japan in the treatment of gynecological malignancies. The JGOG consists of three treatment committees focusing on uterine cervical cancer, endometrial cancer, and ovarian cancer. Each committee makes efforts to improve treatment and diagnosis. In addition, the Supportive and Palliative Care Committee was established in 2015. Novel studies of supportive care and palliative care have been initiated by this committee. Furthermore, surveys about not only treatment results such as overall survival rates but also quality of life (QOL) and cost-effectiveness assessments are performed by the ovarian cancer committee. Improvements of patients' QOL in the treatment of gynecological malignancies were divided into three concepts as follows: QOL associated with cancer treatment, health care after cancer therapy, and progression of cancer. In this review, we report the contributions and future plans for the improvement of QOL in patients with gynecological malignancies.

Indexed as

Asian PeopleFemaleGenital Neoplasms, FemaleGynecologyHumansQuality of LifeSurvival RateGynecological malignanciesJGOGQOLSupportive and Palliative Care Committee

Identifiers

PMID28303492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.